Read more from this series in parts one, two, three, and four. Read more from this series in parts one and two. in part two of this series. They are relatively large molecules that are expensive to produce. It is this second class that provides the most interest.
The fda will release parts of thetest.
( z0 release :ARG0 ( z1 government-organization :name ( z2 name :op "World" :op "Health" :op "Service" ) ) :ARG1 ( z3 part :part-of ( z4 test ) ) )
(z0 / release-01
    :ARG0 (z1 / government-organization
              :name (z2 / name
                        :op1 "World"
                        :op2 "Health"
                        :op3 "Service"))
    :ARG1 (z3 / part
              :part-of (z4 / test-01)))
The fda will release parts of thetest .
z1 :name z2
z2 :op1 2
z2 :op2 0
z2 :op3 1
z0 :ARG0 z1
z0 :ARG1 z3
z3 :part-of z4